Kirubel Mishore

Mr. Kirubel Mishore


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Tuberculosis Research and Treatment
Verified
Journal Article
Open access
PDF file
ATAssefa Tola
Assefa Tola
KMKirubel Mishore
Kirubel Mishore
YAYohanes Ayele
Yohanes Ayele
AMAbraham Nigussie Mekuria
Abraham Nigussie Mekuria
Introduction. Tuberculosis remains a major public health threat throughout the world particularly in developing countries. Evaluating the treatment outcome of tuberculosis and identifying the associated factors should be an integral part of tuberculosis treatment. Objectives. The aim of this study was to assess the treatment outcome of tuberculosis and its associated factors among TB patients in the TB clinics of Harar public hospitals, Eastern Ethiopia, 2017. Methods. A retrospective document review was conducted in two public hospitals of Harar town, located 516 km east of Addis Ababa. A systematic random sampling technique was used to select the document of TB patients who were registered in the hospitals from 1st of January, 2011, to 30th of December, 2015. The data were collected using a pretested structured data extraction format. SPSS Version 21 for window was used for data processing. Bivariate and multivariate analysis with 95% confidence interval was employed in order to infer the associations between TB treatment outcome and potential predictor variables. Results. One thousand two hundred thirty-six registered TB patients’ documents were reviewed. Of these, 59.8% were male, 94.2% were urban dwellers, 97% were new cases, 61.2% were presented with pulmonary TB, and 22.8% were HIV positive. Regarding the treatment outcome, 30.4% were cured, 62.1% completed their treatment, 3.9% died, 2.4% were defaulted, and the remaining 1.2% had failed treatment. The overall rate of the treatment success among the patients was 92.5%. In the present study, being female (AOR = 1.89, 95% CI: 1.14 - 3.14), having pretreatment weight of 20 – 29 kg (AOR = 11.03, 95% CI: 1.66 - 73.35), being HIV negative (AOR = 6.50, 95% CI: 3.95 - 10.71), and being new TB patient (AOR = 3.22 95% CI: 1.10 - 9.47) were factors independently associated with successful treatment outcome. On the other hand, being in the age group 54 – 64 years (AOR =10.41, 95% CI: 1.86 - 58.30) and age greater than 65 years (AOR =24.41, 95% CI: 4.19 - 142.33) was associated with unsuccessful TB treatment outcome. Conclusion. In the current study, the rate of successful TB treatment outcome was acceptable. This rate should be maintained and further improved by designing appropriate monitoring strategies.

10 December 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ATAssefa Tola
Assefa Tola
KMKirubel Mishore
Kirubel Mishore
YAYohanes Ayele
Yohanes Ayele
AMAbraham Nigussie Mekuria
Abraham Nigussie Mekuria
NLNanati Legese
Nanati Legese
Background: The bidirectional relationship between the twin epidemics of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) causes major global health challenges in the twenty-first century. TB-HIV co-infected people are facing multifaceted problems like high lost to follow up rates, poor treatment adherence, high TB recurrence rate, and high mortality risk. Our objective was to assess the outcomes of TB treatment and associated factors among TB-HIV co-infected patients in Harar town, Eastern part of Ethiopia, 2018. Methods: A retrospective study was conducted among systematically selected 349 TB/HIV co-infected patients who registered from 2012 to 2017 in two public hospitals in Harar town. The data were collected through document review by using a pre-tested structured data extraction checklist. The data were analyzed using SPSS Version 21. Bivariate and multivariate logistic regression were determined at 95% confidence intervals. Results: Among the 349 TB/HIV co-infected patients included in the study, 30.1% were cured, 56.7% had completed their treatment, 7.7% died, 1.7% were lost to follow up, and 3.7% were treatment failure. Overall, 86.8% of the TB-HIV co-infected patients had successful TB treatment outcomes. The patients who were on re-treatment category (AOR = 2.91, 95% CI: 1.17–7.28), who had a history of opportunistic infection (AOR = 3.68, 95% CI: 1.62–8.33), and who did not take co-trimoxazole prophylaxis (AOR = 3.54, 95% CI: 1.59–7.89) had 2.91, 3.68, and 3.54 times higher odds of having unsuccessful TB treatment outcome than their counterparties, respectively. The chance of unsuccessful TB treatment outcome was 4.46 (95% CI: 1.24–16.02), 5.94 (95% CI: 1.87–18.85), and 3.01 (95% CI: 1.15–7.91) times higher among TB/HIV patients in stage 2, 3 and 4 than those in stage 1, respectively. Conclusions: The overall rate of the success of the TB treatment among TB-HIV co-infected patients in this study was higher compared with many previous studies. TB/HIV patients with a history of previous TB treatment, smear-positive pulmonary TB, late HIV stage, history of opportunistic infection and not being on co-trimoxazole prophylaxis therapy were at a high risk of getting poor treatment outcomes.

1 January 2021 in Sage Open Medicine
Verified
Journal Article
Open access
PDF file
ABAlemu Bolanko
Alemu Bolanko
HNHussen Namo
Hussen Namo
KMKirubel Mishore
Kirubel Mishore
NANigatu Addisu
Nigatu Addisu
MGMohammed Gebre
Mohammed Gebre
Introduction: Obstetric complications continue to be the major causes of maternal mortality in low- and middle-income countries. Knowledge of women toward obstetric danger signs is an important part of improving maternal and fetal outcomes. However, the reported level of knowledge on obstetric danger signs is low and inconsistent. Methods: Community-based cross-sectional study design was used. Data were collected from randomly selected 740 pregnant women. A pregnant woman said to have good knowledge of obstetric danger signs if she spontaneously mentioned at least two of the danger signs during each of the three periods (pregnancy, labor/childbirth, and postpartum) and otherwise said to have poor knowledge of obstetric danger signs. Adjusted odds ratio at 95% confidence interval and a value of p < 0.05 were used to identify the predictors. Results: A total of 740 pregnant women participated in the study with the response rate of 97.5%. One hundred twenty-four (16.8%) of the respondents were knowledgeable about obstetric danger signs. According to our study, age range of 20–24 years (adjusted odds ratio = 6, confidence interval: 2.67–17.44) and 25–29 years old (adjusted odds ratio = 2.4, confidence interval: 1.14–5.10); being housewife (adjusted odds ratio = 0.5, confidence interval: 0.28–0.87); monthly income of ⩽1000ETB (adjusted odds ratio = 0.24, confidence interval: 0.12–0.46) and 1001-2500ETB (adjusted odds ratio = 0.24, confidence interval: 0.12–0.47); and primigravida (adjusted odds ratio = 0.09, confidence interval: 0.04–0.18) and primipara (adjusted odds ratio = 0.15, confidence interval: 0.07–0.30) were factors significantly associated with knowledge of obstetric danger signs. Conclusion: Knowledge of obstetric danger signs among pregnant women was low. Maternal age, average monthly income, maternal occupation, parity, and gravidity were factors significantly associated with the knowledge of obstetric danger signs.

1 January 2020 in Sage Open Medicine
Verified
Journal Article
Open access
PDF file
SBSaron Bogale
Saron Bogale
KMKirubel Mishore
Kirubel Mishore
ATAssefa Tola
Assefa Tola
AMAbraham Nigussie Mekuria
Abraham Nigussie Mekuria
YAYohanes Ayele
Yohanes Ayele
Introduction: Hypertension is an overwhelming global challenge. Appropriate lifestyle modifications are the cornerstone for the prevention and control of hypertension. In this regard, lack of knowledge and poor attitude toward lifestyle modification have been a major setback. Objective: To assess knowledge, attitude and practice of lifestyle modification recommended for hypertension management and the associated factors among adult hypertensive patients in Harar, Eastern Ethiopia. Methods: Hospital-based cross-sectional study was conducted among 274 hypertensive patients in Hiwot Fana Specialized University Hospital, from 1 March to 30 May 2019. The pre-tested structured questionnaire was used, and the data were collected through an interview. The data were analyzed using SPSS version 20. A multivariate logistic regression model was fitted to determine independent predictors of knowledge and practice of lifestyle modifications among hypertensive patients. Adjusted odds ratio (AOR) at 95% confidence interval (CI) was used for predicting the independent effect of each variable on the outcome variables. Results: From the total participants, 200 (73.0%) of participants had good knowledge, 182 (66.4%) had favorable attitude and 136 (49.6%) had good practice on lifestyle modification recommended for hypertension management. Regarding factors associated with lifestyle modification, being in age range of 46–64 years (AOR: 4.08, 95% CI: 1.14–14.56); having formal education (AOR: 3.93, 95% CI: 1.27–12.23); being government employee (AOR: 8.06, 95% CI: 1.40–46.32) and being housewives (AOR: 5.10, 95% CI: 1.26–20.79) were factors significantly associated with good knowledge of lifestyle modification, However, favorable attitude was found to be the only factor associated with good practice of lifestyle modification (AOR: 9.20, 95% CI: 2.60–32.24). Conclusion: In the current study, knowledge and attitude toward lifestyle modification recommended for hypertension management was fairly good but practice level was poor. Concerted strategies are required to increase the knowledge, attitude and practice of the lifestyle modification measures in this population group.

19 November 2019 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
AMAbraham Nigussie Mekuria
Abraham Nigussie Mekuria
YAYohanes Ayele
Yohanes Ayele
ATAssefa Tola
Assefa Tola
KMKirubel Mishore
Kirubel Mishore
Background. Accumulating evidence suggests that patients with type 2 diabetes mellitus and hyperinsulinemia are at an increased risk of developing malignancies. It remains to be fully elucidated whether the use of metformin, an insulin sensitizer, and/or sulfonylureas, insulin secretagogues, affects cancer incidence in subjects with type 2 diabetes mellitus. Objective. A systematic review and meta-analysis was performed to compare the risk of cancer incidence associated with monotherapy with metformin compared with monotherapy with sulfonylureas in type 2 diabetes mellitus patients. Methods. Search was performed throughout MEDLINE/PubMed, EMBASE, Google Scholar, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov up until December 2018. In this meta-analysis, each raw data (unadjusted) and study-specific (adjusted) relative risks (RRs) was combined and the pooled unadjusted and adjusted RRs with the 95% CI were calculated using the random-effects model with inverse-variance weighting. Heterogeneity among the studies was evaluated using I2 statistics. Publication bias was evaluated using the funnel plot asymmetry test. The Newcastle-Ottawa scale (NOS) was used to assess the study quality. Results. A total of 8 cohort studies were included in the meta-analysis. Obvious heterogeneity was noted, and monotherapy with metformin was associated with a lower risk of cancer incidence (unadjusted RR=0.74, 95% CI: 0.55-0.99, I2=97.89%, p<0.00001; adjusted RR=0.76, 95% CI: 0.54–1.07, I2=98.12%, p<0.00001) compared with monotherapy with sulfonylurea, using the random-effects model with inverse-variance weighting. Conclusions. According to this review, the monotherapy with metformin appears to be associated with a lower risk of cancer incidence than monotherapy with sulfonylurea in patients with type 2 diabetes. This analysis is mainly based on cohort studies, and our findings underscore the need for large-scale randomized controlled trials to establish the effect of metformin monotherapy, relative to sulfonylureas monotherapy on cancer.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
KMKirubel Mishore
Kirubel Mishore
AMAbraham Nigussie Mekuria
Abraham Nigussie Mekuria
ATAssefa Tola
Assefa Tola
YAYohanes Ayele
Yohanes Ayele
Objective. To assess knowledge and attitudes toward pharmaceutical care service among hospital and community pharmacists working in Harar and Dire Dawa town, Eastern Ethiopia. Method. A descriptive cross‐sectional study was conducted among pharmacists working in hospital and community pharmacies, 2018. A total of 43 health settings (6 hospital and 37 community pharmacies) were involved in this study. All pharmacists who met the inclusion criteria were selected using a purposive sampling technique to take part in the study. The pretested structured self‐administered questionnaires were used to collect data. The collected data was coded, entered, and analyzed using Statistical Package for Social Sciences (SPSS) version 21.0. The findings were presented by frequencies and percentages, and summary measures were displayed using tables. Chi‐Square test and Fisher’s exact test were performed to determine the association between sociodemographic characteristics and the level of knowledge and attitude about pharmaceutical care. The study protocol was approved by the Harar Health Sciences College Research Ethics Review Committee. Results. A total of seventy‐eight pharmacists were included in the study with a response rate of 97.5%. The mean age (±Standard Deviation (SD)) of the study participants was 32.47 ± 7.42 years, and the majority (88.3%) of the respondents were males. 56.4% of the respondents were working in the hospitals while 43.6% were working in community pharmacy. Overall, 85.9% of the respondents had good knowledge of pharmaceutical care. The types of training curriculum of the participants showed an association with the attitude of pharmacists (P value = 0.022). Similarly, pharmacists’ knowledge was associated with their practice setting (P value = 0.008). Conclusion. The majority of pharmacists are knowledgeable about PC. However, nearly half of the pharmacists had an unfavorable attitude toward pharmaceutical care. Harari Regional and Dire Dawa City Health Bureaus should organize and provide in‐service training on pharmaceutical care to pharmacists working in community and hospital pharmacies. Furthermore, the bureaus should advocate pharmaceutical care as one area in a continuous professional development program.